世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

世界のマルチプレックス診断市場 2018-2022年

Global Multiplexed Diagnostics Market 2018-2022

IRTNTR23530

 

出版社 出版年月電子版価格 ページ数
TechNavio
テクナビオ
2018年10月US$2,500
シングルユーザライセンス
122

サマリー

この調査レポートは世界のマルチプレックス診断市場を分析・予測したTechNavioの市場調査報告書です。

Description

About Multiplexed Diagnostics
Multiplexed diagnostics refer to the procedure used to analyze multiple analytes in a single cycle of the assay procedure. Multiplexed diagnostics can diagnose and run multiple tests on specimens. These tools are evolved from diagnostic assays that screen a single analyte in a single run of the assay procedure.
Technavio’s analysts forecast the Global Multiplexed Diagnostics Market to grow at a CAGR of 15.23% during the period 2018-2022.

Covered in this report
The report covers the present scenario and the growth prospects of the multiplexed diagnostics market. To calculate the market size, the report considers the revenue generated from the retail sales of multiplexed diagnostic equipment across the globe.

The market is divided into the following segments based on geography:
- Americas
- APAC
- EMEA

Technavio's report, multiplexed diagnostics market 2018-2022, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
- Agilent Technologies
- BD
- BioMerieux
- Merck KGaA
- Roche
- Siemens
- Thermo Fisher Scientific
Market driver
- High prevalence of chronic and infectious diseases
- For a full, detailed list, view our report

Market challenge
- Lack of skilled professionals
- For a full, detailed list, view our report

Market trend
- Increasing technological advances
- For a full, detailed list, view our report

Key questions answered in this report
- What will the market size be in 2022 and what will the growth rate be?
- What are the key market trends?
- What is driving this market?
- What are the challenges to market growth?
- Who are the key vendors in this market space?
- What are the market opportunities and threats faced by the key vendors?
- What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.




目次

PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
PART 03: RESEARCH METHODOLOGY
PART 04: MARKET LANDSCAPE
- Market ecosystem
- Market characteristics
- Market segmentation analysis
PART 05: MARKET SIZING
- Market definition
- Market sizing 2017
- Market size and forecast 2017-2022
PART 06: FIVE FORCES ANALYSIS
- Bargaining power of buyers
- Bargaining power of suppliers
- Threat of new entrants
- Threat of substitutes
- Threat of rivalry
- Market condition
PART 07: CUSTOMER LANDSCAPE
PART 08: MARKET SEGMENTATION BY END-USER
- Segmentation by end-user
- Comparison by end-user
- Pharmaceutical and biotechnology companies - Market size and forecast 2017-2022
- Healthcare centers - Market size and forecast 2017-2022
- Academic institutes and CROs - Market size and forecast 2017-2022
- Market opportunity by end-user
PART 09: REGIONAL LANDSCAPE
- Geographical segmentation
- Regional comparison
- Americas - Market size and forecast 2017-2022
- EMEA - Market size and forecast 2017-2022
- APAC - Market size and forecast 2017-2022
- Market opportunity
PART 10: DECISION FRAMEWORK
PART 11: DRIVERS AND CHALLENGES
- Market drivers
- Market challenges
PART 12: MARKET TRENDS
- Technological advancements
- Increase in personalized medicine
- Increasing number of CROs
PART 13: VENDOR LANDSCAPE
- Overview
- Landscape disruption
PART 14: VENDOR ANALYSIS
- Vendors covered
- Vendor classification
- Market positioning of vendors
- Agilent Technologies
- BD
- BioMerieux
- Merck KGaA
- Roche
- Siemens
- Thermo Fisher Scientific
PART 15: APPENDIX
- List of abbreviations


-
-
Exhibit 01: Parent market
Exhibit 02: Global molecular diagnostics market
Exhibit 03: Market characteristics
Exhibit 04: Market segments
Exhibit 05: Market definition - Inclusions and exclusions checklist
Exhibit 06: Market size 2017
Exhibit 07: Validation techniques employed for market sizing 2017
Exhibit 08: Global multiplexed diagnostics market - Market size and forecast 2017-2022 ($ bn)
Exhibit 09: Global multiplexed diagnostics market - Year-over-year growth 2018-2022 (%)
Exhibit 10: Five forces analysis 2017
Exhibit 11: Five forces analysis 2022
Exhibit 12: Bargaining power of buyers
Exhibit 13: Bargaining power of suppliers
Exhibit 14: Threat of new entrants
Exhibit 15: Threat of substitutes
Exhibit 16: Threat of rivalry
Exhibit 17: Market condition - Five forces 2017
Exhibit 18: Customer landscape
Exhibit 19: End-user - Market share 2017-2022 (%)
Exhibit 20: Comparison by end-user
Exhibit 21: Pharmaceutical and biotechnology companies - Market size and forecast 2017-2022 ($ bn)
Exhibit 22: Pharmaceutical and biotechnology companies - Year-over-year growth 2018-2022 (%)
Exhibit 23: Healthcare centers - Market size and forecast 2017-2022 ($ bn)
Exhibit 24: Healthcare centers - Year-over-year growth 2018-2022 (%)
Exhibit 25: Academic institutes and CROs - Market size and forecast 2017-2022 ($ bn)
Exhibit 26: Academic institutes and CROs - Year-over-year growth 2018-2022 (%)
Exhibit 27: Market opportunity by end-user
Exhibit 28: Global multiplexed diagnostics market - Market share by geography 2017-2022 (%)
Exhibit 29: Regional comparison
Exhibit 30: Americas - Market size and forecast 2017-2022 ($ bn)
Exhibit 31: Americas - Year-over-year growth 2018-2022 (%)
Exhibit 32: Top 3 countries in Americas
Exhibit 33: EMEA - Market size and forecast 2017-2022 ($ bn)
Exhibit 34: EMEA - Year-over-year growth 2018-2022 (%)
Exhibit 35: Top 3 countries in EMEA
Exhibit 36: APAC - Market size and forecast 2017-2022 ($ bn)
Exhibit 37: APAC - Year-over-year growth 2018-2022 (%)
Exhibit 38: Top 3 countries in APAC
Exhibit 39: Market opportunity
Exhibit 40: Vendor landscape
Exhibit 41: Landscape disruption
Exhibit 42: Vendors covered
Exhibit 43: Vendor classification
Exhibit 44: Market positioning of vendors
Exhibit 45: Agilent Technologies overview
Exhibit 46: Agilent Technologies - Business segments
Exhibit 47: Agilent Technologies - Organizational developments
Exhibit 48: Agilent Technologies - Geographic focus
Exhibit 49: Agilent Technologies? Segment focus
Exhibit 50: Agilent Technologies - Key offerings
Exhibit 51: BD overview
Exhibit 52: BD - Business segments
Exhibit 53: BD - Organizational developments
Exhibit 54: BD - Geographic focus
Exhibit 55: BD - Segment focus
Exhibit 56: BD - Key offerings
Exhibit 57: BioMerieux overview
Exhibit 58: BioMerieux - Business segments
Exhibit 59: BioMerieux - Organizational developments
Exhibit 60: BioMerieux - Geographic focus
Exhibit 61: BioMerieux - Segment focus
Exhibit 62: BioMerieux - Key offerings
Exhibit 63: Merck KGaA overview
Exhibit 64: Merck KGaA - Business segments
Exhibit 65: Merck KGaA - Organizational developments
Exhibit 66: Merck KGaA - Geographic focus
Exhibit 67: Merck KGaA - Segment focus
Exhibit 68: Merck KGaA - Key offerings
Exhibit 69: Roche overview
Exhibit 70: Roche - Business segments
Exhibit 71: Roche - Organizational developments
Exhibit 72: Roche - Geographic focus
Exhibit 73: Roche - Segment focus
Exhibit 74: Roche - Key offerings
Exhibit 75: Siemens overview
Exhibit 76: Siemens - Business segments
Exhibit 77: Siemens - Organizational developments
Exhibit 78: Siemens - Geographic focus
Exhibit 79: Siemens - Segment focus
Exhibit 80: Siemens - Key offerings
Exhibit 81: Thermo Fisher Scientific overview
Exhibit 82: Thermo Fisher Scientific - Business segments
Exhibit 83: Thermo Fisher Scientific - Organizational developments
Exhibit 84: Thermo Fisher Scientific - Geographic focus
Exhibit 85: Thermo Fisher Scientific - Segment focus
Exhibit 86: Thermo Fisher Scientific - Key offerings







 

ページTOPに戻る

あなたが最近チェックしたレポート一覧

  • 最近チェックしたレポートはありません。

お問合は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのお問合せはこちらのフォームから承ります

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

<無料>メルマガに登録する

 

 

ページTOPに戻る